Julie Schneider to Off-Label Use
This is a "connection" page, showing publications Julie Schneider has written about Off-Label Use.
Connection Strength
0.051
-
Off-label use of aducanumab for cerebral amyloid angiopathy. Lancet Neurol. 2021 08; 20(8):596-597.
Score: 0.051
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.